AMHASS: Indonesia NCD Health System Analysis

Executive summary

AMHASS is ARC's integrated analysis of Indonesia's non-communicable disease health system, modelling the optimised effective coverage of cardiometabolic risk management alongside in-depth situational reports on diabetes and hypertension. It documents a health system struggling to keep pace with rising NCD burden, with roughly two decades of stagnant premature NCD mortality and a hypertension cascade that falls well short of international control targets. The interactive workbench lets users explore the system-modelling layer behind these reports.

Questions this report answers

• How far does Indonesia's NCD care fall short of international control targets?
• Where does the hypertension and diabetes cascade break down, from diagnosis to control?
• What coverage gains are achievable by optimising the health system's response?

Key findings

• Indonesia's hypertension care cascade reaches 70% diagnosed, 49% treated, and 34% controlled (SKI 2023), against a 70/70/70 global target.
• Indonesia has experienced roughly 20 years of stagnancy in the premature NCD death rate (probability of dying between age 30 and 70 from cardiovascular disease, cancer, diabetes, or chronic respiratory disease).
• On WHO SDG 3.4 monitoring, Indonesia's NCD burden is outpacing the health system's response and lagging Malaysia, Thailand, and India.
• The modelling layer optimises effective coverage of cardiometabolic risk management, paired with descriptive situational analyses of the two principal silent killers, diabetes and hypertension.